U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk

TOPICS:
U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk

Posted By: Advance April 15, 2022

U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk

TG Therapeutics is heading back to the drawing board after new data showed its cancer drug had an elevated risk of death, plucking Ukoniq off the market for the two indications it won accelerated a | TG Therapeutics is heading back to the drawing board after new data showed its cancer drug had an elevated risk of death, plucking Ukoniq off the market for the two indications it won accelerated approval for, in addition to withdrawing an approval request for a combo med.